257 related articles for article (PubMed ID: 1645591)
21. The E2F5 repressor is an activator of E6/E7 transcription and of the S-phase entry in HPV18-associated cells.
Teissier S; Pang CL; Thierry F
Oncogene; 2010 Sep; 29(36):5061-70. PubMed ID: 20639900
[TBL] [Abstract][Full Text] [Related]
22. The E2 transcriptional repressor can compensate for Sp1 activation of the human papillomavirus type 18 early promoter.
Demeret C; Yaniv M; Thierry F
J Virol; 1994 Nov; 68(11):7075-82. PubMed ID: 7933089
[TBL] [Abstract][Full Text] [Related]
23. Transactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell lines.
Goodwin EC; Naeger LK; Breiding DE; Androphy EJ; DiMaio D
J Virol; 1998 May; 72(5):3925-34. PubMed ID: 9557678
[TBL] [Abstract][Full Text] [Related]
24. A novel silencer element in the bovine papillomavirus type 4 promoter represses the transcriptional response to papillomavirus E2 protein.
Vance KW; Campo MS; Morgan IM
J Virol; 2001 Mar; 75(6):2829-38. PubMed ID: 11222708
[TBL] [Abstract][Full Text] [Related]
25. During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element.
Tan SH; Gloss B; Bernard HU
Nucleic Acids Res; 1992 Jan; 20(2):251-6. PubMed ID: 1311070
[TBL] [Abstract][Full Text] [Related]
26. Specific in vitro interaction between papillomavirus E2 proteins and TBP-associated factors.
Carrillo E; Garrido E; Gariglio P
Intervirology; 2004; 47(6):342-9. PubMed ID: 15564746
[TBL] [Abstract][Full Text] [Related]
27. The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID.
Tan SH; Leong LE; Walker PA; Bernard HU
J Virol; 1994 Oct; 68(10):6411-20. PubMed ID: 8083979
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition.
Nishimura A; Ono T; Ishimoto A; Dowhanick JJ; Frizzell MA; Howley PM; Sakai H
J Virol; 2000 Apr; 74(8):3752-60. PubMed ID: 10729150
[TBL] [Abstract][Full Text] [Related]
29. Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters.
Romanczuk H; Thierry F; Howley PM
J Virol; 1990 Jun; 64(6):2849-59. PubMed ID: 2159546
[TBL] [Abstract][Full Text] [Related]
30. Activation of human papillomavirus type 18 E6-E7 oncogene expression by transcription factor Sp1.
Hoppe-Seyler F; Butz K
Nucleic Acids Res; 1992 Dec; 20(24):6701-6. PubMed ID: 1336181
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus E7 repression in cervical carcinoma cells initiates a transcriptional cascade driven by the retinoblastoma family, resulting in senescence.
Johung K; Goodwin EC; DiMaio D
J Virol; 2007 Mar; 81(5):2102-16. PubMed ID: 17182682
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements.
Dong G; Broker TR; Chow LT
J Virol; 1994 Feb; 68(2):1115-27. PubMed ID: 8289341
[TBL] [Abstract][Full Text] [Related]
33. Regulation of human papillomavirus type 11 enhancer and E6 promoter by activating and repressing proteins from the E2 open reading frame: functional and biochemical studies.
Chin MT; Hirochika R; Hirochika H; Broker TR; Chow LT
J Virol; 1988 Aug; 62(8):2994-3002. PubMed ID: 2839716
[TBL] [Abstract][Full Text] [Related]
34. Cell-type-specific separate regulation of the E6 and E7 promoters of human papillomavirus type 6a by the viral transcription factor E2.
Rapp B; Pawellek A; Kraetzer F; Schaefer M; May C; Purdie K; Grassmann K; Iftner T
J Virol; 1997 Sep; 71(9):6956-66. PubMed ID: 9261424
[TBL] [Abstract][Full Text] [Related]
35. Brd4-independent transcriptional repression function of the papillomavirus e2 proteins.
Schweiger MR; Ottinger M; You J; Howley PM
J Virol; 2007 Sep; 81(18):9612-22. PubMed ID: 17626100
[TBL] [Abstract][Full Text] [Related]
36. Competitive binding of viral E2 protein and mammalian core-binding factor to transcriptional control sequences of human papillomavirus type 8 and bovine papillomavirus type 1.
Schmidt HM; Steger G; Pfister H
J Virol; 1997 Oct; 71(10):8029-34. PubMed ID: 9311900
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region.
Butz K; Hoppe-Seyler F
J Virol; 1993 Nov; 67(11):6476-86. PubMed ID: 8411351
[TBL] [Abstract][Full Text] [Related]
38. The E8 repression domain can replace the E2 transactivation domain for growth inhibition of HeLa cells by papillomavirus E2 proteins.
Stubenrauch F; Straub E; Fertey J; Iftner T
Int J Cancer; 2007 Nov; 121(10):2284-92. PubMed ID: 17583574
[TBL] [Abstract][Full Text] [Related]
39. The E2 trans-activator can act as a repressor by interfering with a cellular transcription factor.
Stenlund A; Botchan MR
Genes Dev; 1990 Jan; 4(1):123-36. PubMed ID: 2155158
[TBL] [Abstract][Full Text] [Related]
40. Bovine papillomavirus E2 gene regulates expression of the viral E5 transforming gene.
Prakash SS; Horwitz BH; Zibello T; Settleman J; DiMaio D
J Virol; 1988 Oct; 62(10):3608-13. PubMed ID: 2843663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]